iifl-logo

Valiant Laboratories Ltd Share Price

99.25
(-5.01%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open99.51
  • Day's High106.45
  • 52 Wk High168
  • Prev. Close104.48
  • Day's Low99.25
  • 52 Wk Low 75.2
  • Turnover (lac)35.73
  • P/E0
  • Face Value10
  • Book Value53.28
  • EPS0
  • Mkt. Cap (Cr.)431.24
  • Div. Yield0
View All Historical Data
No Records Found

Valiant Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

99.51

Prev. Close

104.48

Turnover(Lac.)

35.73

Day's High

106.45

Day's Low

99.25

52 Week's High

168

52 Week's Low

75.2

Book Value

53.28

Face Value

10

Mkt Cap (₹ Cr.)

431.24

P/E

0

EPS

0

Divi. Yield

0

Valiant Laboratories Ltd Corporate Action

31 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

17 Jul 2024

12:00 AM

AGM

Announcement Date: 17 Jul, 2024

arrow

Valiant Laboratories Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Valiant Laboratories Ltd SHAREHOLDING SNAPSHOT

26 Apr, 2025|06:15 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 74.93%

Foreign: 0.00%

Indian: 74.93%

Non-Promoter- 0.64%

Institutions: 0.64%

Non-Institutions: 24.41%

Custodian: 0.00%

Share Price

Valiant Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

43.45

32.56

16.28

10.5

Preference Capital

0

0

0

0

Reserves

193.43

67.93

55.18

78.08

Net Worth

236.88

100.49

71.46

88.58

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023

Gross Sales

182.06

333.91

Excise Duty

0

0

Net Sales

182.06

333.91

Other Operating Income

0

0

Other Income

9.68

4.86

Valiant Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,803.9

137.434,32,9601,181.050.755,985.3398.33

Divis Laboratories Ltd

DIVISLAB

6,215.5

79.591,65,003.325940.482,297513.62

Cipla Ltd

CIPLA

1,551.7

26.921,25,285.641,438.150.844,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,325.1

61.671,12,502.674850.842,330222.38

Mankind Pharma Ltd

MANKIND

2,599.2

55.531,07,385.94416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Valiant Laboratories Ltd

Management

Register Office

Registrar Office

Managing Director

Santosh S. Vora

Director

Shantilal Shivji Vora

Executive Director

Paresh Shashikant Shah

Independent Director

Sonal A Vira

Addtnl Non-Executive Director

Sandeep Gupta..

Company Sec. & Compli. Officer

Saloni Mehta

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the C
Read More

Company FAQs

What is the Valiant Laboratories Ltd share price today?

The Valiant Laboratories Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹99.25 today.

What is the Market Cap of Valiant Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Valiant Laboratories Ltd is ₹431.24 Cr. as of 25 Apr ‘25

What is the PE and PB ratio of Valiant Laboratories Ltd?

The PE and PB ratios of Valiant Laboratories Ltd is 0 and 2.03 as of 25 Apr ‘25

What is the 52 Week High and Low of Valiant Laboratories Ltd?

The 52-week high/low is the highest and lowest price at which a Valiant Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Valiant Laboratories Ltd is ₹75.2 and ₹168 as of 25 Apr ‘25

What is the CAGR of Valiant Laboratories Ltd?

Valiant Laboratories Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at -33.66%, 6 Month at -5.70%, 3 Month at -0.17% and 1 Month at 24.46%.

What is the shareholding pattern of Valiant Laboratories Ltd?

The shareholding pattern of Valiant Laboratories Ltd is as follows:
Promoters - 74.94 %
Institutions - 0.64 %
Public - 24.42 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.